-
Trametinib (GSK1120212): Precision Oncology Tool for Heterog
2026-07-24
Explore Trametinib (GSK1120212) as a precision research tool for dissecting therapeutic heterogeneity in cancer models. This in-depth analysis uniquely connects MEK inhibition to practical assay design and advances in personalized oncology.
-
Hepatic Uptake of PEGylated Iron Oxide Nanoparticles: Cellul
2026-07-24
This study dissects how nanoparticle size and PEG chain length govern hepatic cellular interactions and biodistribution, challenging established assumptions about liver clearance mechanisms. The findings provide actionable design principles for nanomedicines aiming to optimize specificity while minimizing off-target hepatic accumulation.
-
Cy3 NHS ester (non-sulfonated): Protocols for Precise Biomol
2026-07-23
Cy3 NHS ester (non-sulfonated) enables covalent fluorescent labeling of amino groups in proteins, peptides, and oligonucleotides, providing robust orange emission for biomedical imaging. It is best used when high labeling efficiency and compatibility with organic solvents are acceptable, but is not recommended for applications requiring water-only labeling conditions or long-term storage of dye solutions.
-
Graphene-Induced Apoptosis in Melanoma: Caspase-9 Pathway In
2026-07-23
This study demonstrates that graphene nanomaterials induce intrinsic apoptosis and hypoxic stress in melanoma cells via the caspase-9 pathway. These findings advance our understanding of graphene’s bioactivity and highlight caspase-9 as a critical target for dissecting mitochondrial apoptosis in cancer research.
-
Adefovir (GS-0393): Optimizing HBV Antiviral Research Workfl
2026-07-22
Adefovir (GS-0393) stands out as a benchmark HBV antiviral tool, combining robust DNA polymerase inhibition with selective renal transporter probing. This guide details actionable workflows, critical troubleshooting, and the latest safety insights to ensure reproducible, high-fidelity research outcomes.
-
v-Agatoxin-IVA Reveals Complexity in Neuronal Ca Channel Blo
2026-07-22
Sidach and Mintz (2000) redefined the pharmacological selectivity of v-Agatoxin-IVA, demonstrating that, while highly potent against P-type calcium channels, the toxin also exhibits low-affinity blockade of N-type channels at higher concentrations. These findings challenge long-held assumptions about channel subtype discrimination and impact the interpretation of calcium channel research in neuronal systems.
-
JPA Method Enhances LC-MS Metabolomics Chemical Coverage
2026-07-21
The reference study introduces JPA, a joint metabolic feature extraction tool that significantly expands the detection of metabolic and exposomic compounds in LC-MS data. By integrating conventional and novel peak recognition methods, JPA recovers low-abundance and poorly shaped features often missed by standard algorithms, supporting more comprehensive biomarker discovery and exposure assessment.
-
Taxus chinensis Fruit Extract Inhibits Neuroinflammation via
2026-07-21
This study demonstrates that Taxus chinensis (Pilg.) Rehder fruit extract (TCFE) attenuates aging behaviors and neuroinflammation by targeting the TLR4/NF-κB/NLRP3 pathway and suppressing microglial activation. The findings establish a mechanistic basis for plant-derived interventions in age-related neuroinflammatory processes and offer new directions for translational research.
-
Catalpol Targets EphA2/FAK/Src to Inhibit HSC Glycolysis in
2026-07-20
This study demonstrates that catalpol directly inhibits hepatic stellate cell activation and aerobic glycolysis in liver fibrosis by targeting the EphA2/FAK/Src signaling pathway. The findings highlight a new mechanistic link between metabolic reprogramming and fibrogenesis, suggesting novel avenues for anti-fibrotic intervention.
-
Cell Counting Kit-8 (CCK-8): Precision in Cancer Cell Viabil
2026-07-20
Unlock sensitive, streamlined cell viability and cytotoxicity analysis with Cell Counting Kit-8 (CCK-8). This WST-8–based assay enables reproducible, high-throughput workflows in cancer research and beyond—outperforming traditional tetrazolium-based methods for both ease and accuracy.
-
Gap26 Connexin 43 Mimetic Peptide: Advanced Applications & W
2026-07-19
Gap26 unlocks precise control of intercellular signaling in vascular, neuronal, and mitochondrial transfer studies. This guide details experimental workflows, troubleshooting strategies, and actionable insights for maximizing data clarity using APExBIO’s validated connexin 43 mimetic peptide.
-
YM 58483 (BTP2): Unveiling SOCE Inhibition for Fibrosis and
2026-07-18
Explore the science behind YM 58483, a potent SOCE blocker, and discover its advanced applications in fibrosis and immune assays. This article reveals novel mechanistic insights and practical guidance for researchers using YM 58483 (BTP2).
-
TAK1 Stabilization of YAP Regulates Gastric Cancer Stemness
2026-07-17
This study reveals that TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), driving self-renewal and tumorigenesis in gastric cancer stem cells. These insights clarify a critical mechanism of chemoresistance and tumor progression, offering new directions for targeted therapies and research model optimization.
-
iRhom2 Regulates Olfactory Receptor Dynamics in Sensory Neur
2026-07-17
Azzopardi et al. (2024) reveal that iRhom2 is selectively expressed in olfactory sensory neurons and modulates odorant receptor expression and adaptation via the ADAM17 pathway. This study uncovers a feedback mechanism by which odor exposure alters iRhom2 activity, refining our understanding of sensory plasticity and receptor repertoire regulation.
-
Trichostatin A: Precision Epigenetic Modulation in Genetic C
2026-07-16
Explore how Trichostatin A (TSA) empowers advanced epigenetic regulation and cell cycle control in cancer research and synthetic biology. This article reveals unique insights into TSA's role in reversing epigenetic silencing, bridging rigorous science and practical protocols.
448 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page